1. Home
  2. ACHV vs BOT Comparison

ACHV vs BOT Comparison

Compare ACHV & BOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.59

Market Cap

618.0M

Sector

Health Care

ML Signal

N/A

Logo RoboStrategy Inc. Common Stock

BOT

RoboStrategy Inc. Common Stock

N/A

Current Price

$31.67

Market Cap

627.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ACHV
BOT
Founded
N/A
N/A
Country
United States
Puerto Rico
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
618.0M
627.1M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
ACHV
BOT
Price
$7.59
$31.67
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.1M
445.9K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$23.60
52 Week High
$7.34
$43.72

Technical Indicators

Market Signals
Indicator
ACHV
BOT
Relative Strength Index (RSI) 73.79 54.74
Support Level $4.04 $30.34
Resistance Level N/A $37.20
Average True Range (ATR) 0.33 3.10
MACD 0.08 0.59
Stochastic Oscillator 98.71 72.91

Price Performance

Historical Comparison
ACHV
BOT

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About BOT RoboStrategy Inc. Common Stock

RoboStrategy Inc is a closed-end, non-diversified management investment company. The Fund's investment objective is to seek long-term capital appreciation, principally through capital gains on equity and equity-linked investments in robotics and embodied AI companies. The Fund focuses on private, venture-capital-backed companies with growth potential, many of which are not yet publicly listed or widely accessible to individual investors.

Share on Social Networks: